Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Household dampness and microbial exposure related to allergy and respiratory health in Danish adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Inspiratory muscle strength and walking capacity in patients with COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. NIV for acute respiratory failure in COPD: high in-hospital mortality is determined by patient selection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. SPEF2- And HYDIN-mutant cilia lack the central pair-associated protein SPEF2, aiding primary ciliary dyskinesia diagnostics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of structural changes in the lungs. Spirometry-controlled chest CT (SCCCT) has improved the usefulness of CT by standardising inspiratory and expiratory lung volumes during imaging. This was a single-centre cross-sectional study in children with cystic fibrosis (CF). Using SCCCT we wished to investigate the association between the quantity and extent of structural lung changes and pulmonary function outcomes, and prevalence of known CF lung pathogens. Methods: CT images were analysed by CF-CT scoring (expressed as % of maximum score) to quantify different aspects of structural lung changes including bronchiectasis, airway wall thickening, mucus plugging, opacities, cysts, bullae and gas trapping. Clinical markers consisted of outcomes from pulmonary function tests, microbiological cultures from sputum and serological samples reflecting anti-bacterial and anti-fungal antibodies. Results: Sixty-four children with CF, median age (range) of 12.7 (6.4-18.1) years, participated in the study. The median (range) CF-CT total score in all children was 9.3% (0.4-46.8) with gas trapping of 40.7% (3.7-100) as the most abundant finding. Significantly higher median CF-CT total scores (21.9%) were found in patients with chronic infections (N = 12) including Gram-negative infection and allergic bronchopulmonary aspergillosis (ABPA) exhibiting CF-CT total scores of 14.2% (ns) and 24.0% (p < 0.01), respectively, compared to 8.0% in patients with no chronic lung infection. Lung clearance index (LCI) derived from multiple breath washout exhibited closest association with total CF-CT scores, compared to other pulmonary function outcomes. Conclusions: The most prominent structural lung change was gas trapping, while CF-CT total scores were generally low, both showing close association with LCI. Chronic lung infections, specifically in the form of ABPA, were associated with increased scores in lung changes. Further investigation of impact of infections with different microorganisms on extent and progression of structural CF lung disease is needed.

OriginalsprogEngelsk
TidsskriftEuropean Clinical Respiratory Journal
Vol/bind4
Udgave nummer1
Sider (fra-til)e1318027
ISSN2001-8525
DOI
StatusUdgivet - 2017

ID: 52169986